M. Souli

发表

Epidemiology and molecular characterisation of metallo-β-lactamase-producing Enterobacteriaceae in a university hospital Intensive Care Unit in Greece.

A. Armaganidis, E. Koratzanis, M. Souli, 2011, International journal of antimicrobial agents.

Antimicrobial activity of copper surfaces against carbapenemase-producing contemporary Gram-negative clinical isolates.

A. Armaganidis, G. Petrikkos, D. Plachouras, 2013, The Journal of antimicrobial chemotherapy.

Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.

M. Souli, I. Galani, Z. Chryssouli, 2010, International journal of antimicrobial agents.

In vitro evaluation of double‐carbapenem combinations against OXA‐48‐producing Klebsiella pneumoniae isolates using time‐kill studies

M. Souli, I. Galani, Konstantina Nafplioti, 2018, Journal of medical microbiology.

Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016.

M. Souli, I. Galani, H. Giamarellou, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Treating infections caused by carbapenemase-producing Enterobacteriaceae.

G. Daikos, M. Souli, A. Markogiannakis, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece

V. Sakka, S. Tsiodras, D. Plachouras, 2014, BMC Public Health.

A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab

S. Loukides, M. Souli, A. Koumarianou, 2016, Drug target insights.

Present and Emerging Therapies for the Treatment of Drug-resistant Infections: Focus on Linezolid

M. Souli, 2010 .

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolates?

M. Souli, I. Galani, Z. Chryssouli, 2009, Antimicrobial Agents and Chemotherapy.

Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.

G. Petrikkos, M. Souli, I. Galani, 2014, International journal of antimicrobial agents.

Risk Factors for Recurrent Staphylococcus aureus Bacteremia.

B. Sharma-Kuinkel, F. Ruffin, V. Fowler, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mechanisms responsible for imipenem resistance among Pseudomonas aeruginosa clinical isolates exposed to imipenem concentrations within the mutant selection window.

M. Souli, I. Galani, H. Giamarellou, 2017, Diagnostic microbiology and infectious disease.

In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

Stefanos Boukovalas, M. Souli, I. Galani, 2011, Antimicrobial Agents and Chemotherapy.

Discrepancies between various methods in susceptibility testing and epidemiological analysis of Stenotrophomonas maltophilia clinical isolates.

M. Souli, I. Galani, H. Giamarellou, 2010, Central European journal of public health.

Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.

N. Siafakas, V. Sakka, S. Tsiodras, 2009, International journal of antimicrobial agents.

Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003.

M. Souli, I. Galani, Z. Chryssouli, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens

M. Souli, I. Galani, H. Giamarellou, 2019, Expert opinion on drug metabolism & toxicology.

Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.

J. Thaden, B. Sharma-Kuinkel, F. Ruffin, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reduction of Environmental Contamination With Multidrug-Resistant Bacteria by Copper-Alloy Coating of Surfaces in a Highly Endemic Setting

A. Armaganidis, G. Petrikkos, A. Antoniadou, 2017, Infection Control & Hospital Epidemiology.

Characterization of a Dual Cellulolytic/Xylanolytic AA9 Lytic Polysaccharide Monooxygenase from Thermothelomyces thermophilus and its Utilization Toward Nanocellulose Production in a Multi-Step Bioprocess

A. Karantonis, A. Karnaouri, E. Topakas, 2022, ACS Sustainable Chemistry & Engineering.

Evolution of resistance patterns and identification of risk factors for Streptococcus pneumoniae colonisation in daycare centre attendees in Athens, Greece.

P. Ziakas, M. Souli, H. Giamarellou, 2006, International journal of antimicrobial agents.

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

M. Souli, I. Galani, H. Giamarellou, 2019, BMC Infectious Diseases.

Colistin susceptibility testing by Etest and disk diffusion methods.

E. Koratzanis, M. Souli, I. Galani, 2008, International journal of antimicrobial agents.

Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria

M. Polemis, A. Vatopoulos, A. Antoniadou, 2013, Scandinavian journal of infectious diseases.

In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens.

G. Eliopoulos, M. Souli, C. Wennersten, 1998, International journal of antimicrobial agents.

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.

M. Souli, I. Galani, H. Giamarellou, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Activities of Taurolidine In Vitro and in Experimental Enterococcal Endocarditis

G. Eliopoulos, R. Sofia, M. Souli, 2000, Antimicrobial Agents and Chemotherapy.

Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.

J. Thaden, F. Ruffin, V. Fowler, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

In Vivo Activities of Evernimicin (SCH 27899) against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci in Experimental Endocarditis

G. Eliopoulos, M. Souli, C. Thauvin-Eliopoulos, 2000, Antimicrobial Agents and Chemotherapy.

Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.

A. Armaganidis, A. Antoniadou, E. Koratzanis, 2007, The Journal of antimicrobial chemotherapy.

In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.

E. Petinaki, A. Antoniadou, M. Souli, 2020, The Journal of antimicrobial chemotherapy.

In Vitro Activity of Tigecycline against Multiple-Drug-Resistant, Including Pan-Resistant, Gram-Negative and Gram-Positive Clinical Isolates from Greek Hospitals

A. Antoniadou, E. Koratzanis, M. Souli, 2006, Antimicrobial Agents and Chemotherapy.

Characterization of 16S rRNA methylase genes in Enterobacterales and Pseudomonas aeruginosa in Athens Metropolitan area, 2015–2016

V. Baka, A. Antoniadou, M. Souli, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

A. Antoniadou, M. Souli, I. Galani, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

A. Antoniadou, M. Souli, I. Galani, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece.

V. Baka, A. Antoniadou, M. Souli, 2020, Microbial drug resistance.

Practice Point 39 – Management Strategies for Drug-Resistant Infections

G. Daikos, A. Antoniadou, M. Souli, 2017 .

Plazomicin: an investigational therapy for the treatment of urinary tract infections

M. Souli, H. Giamarellou, I. Karaiskos, 2015, Expert opinion on investigational drugs.

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece

G. Petrikkos, G. Daikos, M. Souli, 2012, Journal of chemotherapy.

Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae.

D. Plachouras, M. Souli, I. Galani, 2008, The Journal of antimicrobial chemotherapy.

Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.

E. Koratzanis, M. Souli, I. Galani, 2007, The Journal of antimicrobial chemotherapy.

Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019

A. Antoniadou, M. Souli, I. Galani, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from the United States and Their Susceptibility In Vitro to Dalfopristin-Quinupristin

G. Eliopoulos, G. Talbot, R. Moellering, 1998, Antimicrobial Agents and Chemotherapy.

Comparison of direct antimicrobial susceptibility testing methods for rapid analysis of bronchial secretion samples in ventilator-associated pneumonia.

A. Armaganidis, A. Antoniadou, M. Souli, 2011, International journal of antimicrobial agents.

Vancomycin levels in human aqueous humour after intravenous and subconjunctival administration.

M. Souli, H. Giamarellou, E. Kavouklis, 2001, International journal of antimicrobial agents.

In vivo transmission of a plasmid containing the KPC-2 gene in a single patient.

M. Souli, I. Galani, Z. Chryssouli, 2013, Journal of global antimicrobial resistance.

Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective

G. Daikos, M. Souli, L. Tzouvelekis, 2012, Expert review of anti-infective therapy.

Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.

R. Koncan, J. Frère, V. Miriagou, 2007, International journal of antimicrobial agents.

Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum β-lactamases VEB-1 and SHV-5, metallo-β-lactamase VIM-1, and RNA methylase RmtB.

M. Souli, I. Galani, H. Giamarellou, 2013, Journal of global antimicrobial resistance.

Requirements for Designing an Effective Metallic Nanoparticle (NP)-Boosted Radiation Therapy (RT)

A. Georgakilas, E. Efstathopoulos, L. Sihver, 2021, Cancers.

Colistin: still a lifesaver for the 21st century?

M. Souli, I. Galani, H. Giamarellou, 2017, Expert opinion on drug metabolism & toxicology.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

A. Oliver, E. Pérez-Nadales, R. Bonomo, 2017, The Lancet. Infectious diseases.

Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.

M. Souli, I. Galani, Z. Chryssouli, 2005, The Journal of antimicrobial chemotherapy.

An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.

A. Armaganidis, A. Antoniadou, M. Souli, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

A. Oliver, R. Bonomo, Y. Carmeli, 2016, Antimicrobial Agents and Chemotherapy.

Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.

T. Tsaganos, E. Giamarellos‐Bourboulis, M. Souli, 2007, The Journal of antimicrobial chemotherapy.

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

Y. Carmeli, G. Cornaglia, S. Harbarth, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.

A. Armaganidis, M. Souli, I. Galani, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasmid‐mediated quinolone resistance determinants among Gram‐negative bacteraemia isolates: a hidden threat

G. Petrikkos, M. Souli, I. Galani, 2017, Journal of medical microbiology.

Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures.

A. Antoniadou, M. Souli, I. Galani, 2011, International journal of antimicrobial agents.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, A. Oliver, R. Bonomo, 2018, International journal of antimicrobial agents.

First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1

M. Souli, I. Galani, Z. Chryssouli, 2004 .

Emergence of Klebsiella pneumoniae co-producing OXA-48, CTX-M-15, and ArmA in Greece.

M. Souli, I. Galani, G. Petrikkos, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Safety of a Carbapenem-Sparing Approach as Part of an Antibiotic Stewardship Program, in a Setting with Increased Carbapenem Resistance

D. Matthaiou, A. Antoniadou, M. Souli, 2019, Infectious Diseases and Clinical Microbiology.

Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae

M. Souli, H. Giamarellou, I. Karaiskos, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Applying Broadband Dielectric Spectroscopy (BDS) for the Biophysical Characterization of Mammalian Tissues under a Variety of Cellular Stresses

N. Kostomitsopoulos, L. Margaritis, D. Kletsas, 2017, International journal of molecular sciences.

ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.

E. Kuijper, J. Lucet, J. Price, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Complex DNA Damage: A Route to Radiation-Induced Genomic Instability and Carcinogenesis

K. Aziz, E. Rogakou, A. Georgakilas, 2017, Cancers.

Detection of CTX-M-15 and CTX-M-33, a novel variant of CTX-M-15, in clinical Escherichia coli isolates in Greece.

M. Souli, I. Galani, Z. Chryssouli, 2007, International journal of antimicrobial agents.

Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome

M. Bauer, T. Tsaganos, V. Oberle, 2017, Critical Care.

Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection

Anastasia Antonopoulou, Apostolos Armaganidis, Ioannis Koutelidakis, 2010, Critical care.

Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients

G. Nikolopoulos, M. Souli, H. Giamarellou, 2012, BMC Infectious Diseases.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

A. Antoniadou, M. Souli, I. Galani, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Black and White Patients with Staphylococcus aureus Bacteremia have Similar Outcomes but Different Risk Factors.

B. Sharma-Kuinkel, F. Ruffin, V. Fowler, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.

N. Siafakas, V. Sakka, S. Tsiodras, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

R. Schooley, P. Tamma, D. Conrad, 2022, Trials.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

A. Oliver, R. Bonomo, Y. Carmeli, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012–2013

V. Baka, M. Souli, H. Giamarellou, 2016, Infectious diseases.

[Prevalence of Toxoplasma gondii infection in Tunisian sheep].

M. Souli, M. Gharbi, M. Darghouth, 2013, Bulletin de la Societe de pathologie exotique.

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

A. Oliver, R. Bonomo, Y. Carmeli, 2016, Mayo Clinic proceedings.

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.

A. Antoniadou, M. Souli, I. Galani, 2019, Clinical Microbiology and Infection.

Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

G. Petrikkos, M. Souli, I. Galani, 2012, The Journal of antimicrobial chemotherapy.

Characterization of 16S rRNA methylase genes in Enterobacterales and Pseudomonas aeruginosa in Athens Metropolitan area, 2015–2016

V. Baka, A. Antoniadou, M. Souli, 2020, European Journal of Clinical Microbiology & Infectious Diseases.

The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort

D. Cyr, J. Thaden, F. Ruffin, 2017, Open forum infectious diseases.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

A. Antoniadou, M. Souli, I. Galani, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Effects of Slime Produced by Clinical Isolates of Coagulase-Negative Staphylococci on Activities of Various Antimicrobial Agents

M. Souli, H. Giamarellou, 1998, Antimicrobial Agents and Chemotherapy.

Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid

M. Souli, I. Galani, Z. Chryssouli, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Antibacterial Resistance Leadership Group 2.0 - Back to Business.

Robin Patel, E. Tsalik, P. Tamma, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of Antimicrobial Prophylaxis on Asymptomatic Bacteriuria and Predictors of Failure in Patients with Multiple Sclerosis

M. Souli, H. Giamarellou, K. Kanellakopoulou, 2010, Journal of chemotherapy.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, R. Bonomo, Y. Carmeli, 2018, International journal of antimicrobial agents.

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.

M. Souli, I. Galani, H. Giamarellou, 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.